Revealing the Absence of Microbiota in Hypertrophic Mucosa of Inferior Turbinate

ORIGINAL ARTICLE
Rangga Putra Nugraha, Asti Widuri, Luh Putu Lusy Indrawati, Budi Yuli Setianto, Mahyarudin Mahyarudin, Mardhia Mardhia, Delima Fajar Liana

 
For citation: Nugraha RP, Widuri A, Indrawati LPL, Setianto BY, Mahyarudin M, Mardhia M, Liana DF. Revealing the Absence of Microbiota in Hypertrophic Mucosa of Inferior Turbinate. International Journal of Biomedicine. 2025;15(1):95-100. doi:10.21103/Article15(1)_OA7
 
Originally published March 5, 2025

Abstract: 

Background: Nasal congestion is the most common symptom presented in daily clinical practice, and inferior turbinate hypertrophy (ITH) is the most frequent cause. However, histopathological analysis of turbinate hypertrophy remains unclear. Therefore, this study aimed to assess the presence of microbiota in the mucosa of ITH, to clarify the role in nonspecific immune responses.
Methods and Results: This prospective and cross-sectional study evaluated microbiota in hypertrophic inferior turbinate mucosa. A total of 42 patients and specimens of ITH were enrolled during the endoscopic submucosal rhinoplasty. Intraoperative specimens were collected and inserted into DNA/RNA protectors.The specimens were subjected to DNA extraction, which was followed by PCR electrophoresis. The results showed that metagenomic examination was needed to assess microbiota diversity in tissue, including electrophoresis and sequencing of PCR-amplified DNA such as 16S rRNA in the inferior concha mucosa and the preservation fluid. In this examination, no bands were found at the 1500 bp marker, showing that no bacterial 16S gene fragments were present in either tissue specimen or preservation fluid.
Conclusion: Microbiota were found only in mucus or the nasal mucosa lining and not in the tissue. The results further emphasized the position and role of microbiota as a physiological nonspecific immune response, providing a basis for further studies in learning about microbiota of the respiratory tract, specifically the nasal cavity.

Keywords: 
microbiota • inferior turbinate hypertrophy • nonspesific immune response • sinusitis
References: 
  1. Moubayed SP, Most SP. Evaluation and Management of the Nasal Airway. Clin Plast Surg. 2022 Jan;49(1):23-31. doi: 10.1016/j.cps.2021.08.001. Epub 2021 Sep 11. PMID: 34782137.
  2. Karamatzanis I, Kosmidou P, Ntarladima V, Catalli B, Kosmidou A, Filippou D, Georgalas C. Inferior Turbinate Hypertrophy: A Comparison of Surgical Techniques. Cureus. 2022 Dec 15;14(12):e32579. doi: 10.7759/cureus.32579. PMID: 36654608; PMCID: PMC9840750.
  3. von Mutius E. The microbial environment and its influence on asthma prevention in early life. J Allergy Clin Immunol. 2016 Mar;137(3):680-9. doi: 10.1016/j.jaci.2015.12.1301. Epub 2016 Jan 22. PMID: 26806048.
  4. Hyun DW, Min HJ, Kim MS, Whon TW, Shin NR, Kim PS, Kim HS, Lee JY, Kang W, Choi AMK, Yoon JH, Bae JW. Dysbiosis of Inferior Turbinate Microbiota Is Associated with High Total IgE Levels in Patients with Allergic Rhinitis. Infect Immun. 2018 Mar 22;86(4):e00934-17. doi: 10.1128/IAI.00934-17. PMID: 29426044; PMCID: PMC5865026.
  5. Bomar L, Brugger SD, Lemon KP. Bacterial microbiota of the nasal passages across the span of human life. Curr Opin Microbiol. 2018 Feb;41:8-14. doi: 10.1016/j.mib.2017.10.023. Epub 2017 Nov 20. PMID: 29156371; PMCID: PMC5862745.
  6. Oh J, Conlan S, Polley EC, Segre JA, Kong HH. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 2012 Oct 10;4(10):77. doi: 10.1186/gm378. PMID: 23050952; PMCID: PMC3580446.
  7. Biswas K, Hoggard M, Jain R, Taylor MW, Douglas RG. The nasal microbiota in health and disease: variation within and between subjects. Front Microbiol. 2015 Mar 2;9:134. doi: 10.3389/fmicb.2015.00134. PMID: 25784909; PMCID: PMC5810306.
  8. Wagner Mackenzie B, Waite DW, Hoggard M, Douglas RG, Taylor MW, Biswas K. Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis. Environ Microbiol. 2017 Jan;19(1):381-392. doi: 10.1111/1462-2920.13632. Epub 2017 Jan 18. PMID: 27902866.
  9. Abreu NA, Nagalingam NA, Song Y, Roediger FC, Pletcher SD, Goldberg AN, Lynch SV. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med. 2012 Sep 12;4(151):151ra124. doi: 10.1126/scitranslmed.3003783. PMID: 22972842; PMCID: PMC4786373.
  10. Feazel LM, Robertson CE, Ramakrishnan VR, Frank DN. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis. Laryngoscope. 2012 Feb;122(2):467-72. doi: 10.1002/lary.22398. Epub 2012 Jan 17. PMID: 22253013; PMCID: PMC3398802.
  11. Boase S, Foreman A, Cleland E, Tan L, Melton-Kreft R, Pant H, Hu FZ, Ehrlich GD, Wormald PJ. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis. 2013 May 8;13:210. doi: 10.1186/1471-2334-13-210. PMID: 23656607; PMCID: PMC3654890.
  12. Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, Relman DA. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe. 2013 Dec 11;14(6):631-40. doi: 10.1016/j.chom.2013.11.005. PMID: 24331461; PMCID: PMC3902146.
  13. Ramakrishnan VR, Feazel LM, Abrass LJ, Frank DN. Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma. Int Forum Allergy Rhinol. 2013 Apr;3(4):267-71. doi: 10.1002/alr.21101. Epub 2012 Oct 10. PMID: 23055295.
  14. Hoggard M, Biswas K, Zoing M, Wagner Mackenzie B, Taylor MW, Douglas RG. Evidence of microbiota dysbiosis in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017 Mar;7(3):230-239. doi: 10.1002/alr.21871. Epub 2016 Nov 23. PMID: 27879060.
  15. Cope EK, Goldberg AN, Pletcher SD, Lynch SV. Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences. Microbiome. 2017 May 12;5(1):53. doi: 10.1186/s40168-017-0266-6. PMID: 28494786; PMCID: PMC5427582.
  16. Ramakrishnan VR, Holt J, Nelson LF, Ir D, Robertson CE, Frank DN. Determinants of the Nasal Microbiome: Pilot Study of Effects of Intranasal Medication Use. Allergy Rhinol (Providence). 2018 Aug 2;9:2152656718789519. doi: 10.1177/2152656718789519. PMID: 30128169; PMCID: PMC6088474.
  17. Mahdavinia M, Engen PA, LoSavio PS, Naqib A, Khan RJ, Tobin MC, Mehta A, Kota R, Preite NZ, Codispoti CD, Tajudeen BA, Schleimer RP, Green SJ, Keshavarzian A, Batra PS. The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients. J Allergy Clin Immunol. 2018 Jul;142(1):287-290.e4. doi: 10.1016/j.jaci.2018.01.033. Epub 2018 Feb 13. PMID: 29452201; PMCID: PMC6890201.
  18. Kuhar HN, Tajudeen BA, Mahdavinia M, Heilingoetter A, Ganti A, Gattuso P, Ghai R, Batra PS. Relative abundance of nasal microbiota in chronic rhinosinusitis by structured histopathology. Int Forum Allergy Rhinol. 2018 Dec;8(12):1430-1437. doi: 10.1002/alr.22192. Epub 2018 Sep 21. PMID: 30240151.
  19. Koeller K, Herlemann DPR, Schuldt T, Ovari A, Guder E, Podbielski A, Kreikemeyer B, Olzowy B. Microbiome and Culture Based Analysis of Chronic Rhinosinusitis Compared to Healthy Sinus Mucosa. Front Microbiol. 2018 Apr 17;9:643. doi: 10.3389/fmicb.2018.00643. PMID: 29755418; PMCID: PMC5932350.
  20. Gan W, Yang F, Meng J, Liu F, Liu S, Xian J. Comparing the nasal bacterial microbiome diversity of allergic rhinitis, chronic rhinosinusitis and control subjects. Eur Arch Otorhinolaryngol. 2021 Mar;278(3):711-718. doi: 10.1007/s00405-020-06311-1. Epub 2020 Aug 28. PMID: 32860131.
  21. Alammar Y, Rousseau S, Desrosiers M, Tewfik MA. The Effect of Corticosteroids on Sinus Microbiota in Chronic Rhinosinusitis Patients with Nasal Polyposis. Am J Rhinol Allergy. 2023 Nov;37(6):638-645. doi: 10.1177/19458924231183848. Epub 2023 Jul 20. PMID: 37475202; PMCID: PMC10548776.
  22. Fernández-Rodríguez D, Cho J, Chisari E, Citardi MJ, Parvizi J. Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial. Sci Rep. 2024 Jul 20;14(1):16739. doi: 10.1038/s41598-023-46792-8. PMID: 39033201; PMCID: PMC11271270.

Download Article
Received December 18, 2024.
Accepted January 28, 2025.
©2025 International Medical Research and Development Corporation.